Market closed
Lixte Biotechnology Holdings Inc./$LIXT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
Ticker
$LIXT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
2
Website
LIXT Metrics
BasicAdvanced
$3.2M
-
-$1.59
0.19
-
Price and volume
Market cap
$3.2M
Beta
0.19
52-week high
$1.47
52-week low
$1.02
Average daily volume
24K
Financial strength
Current ratio
3.599
Quick ratio
3.264
Interest coverage (TTM)
-212.40%
Management effectiveness
Return on assets (TTM)
-81.88%
Return on equity (TTM)
-148.73%
Valuation
Price to book
-1
Price to tangible book (TTM)
-1
Price to free cash flow (TTM)
-0.846
Growth
Earnings per share change (TTM)
-39.96%
3-year earnings per share growth (CAGR)
-31.65%
LIXT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Lixte Biotechnology Holdings Inc. stock?
Lixte Biotechnology Holdings Inc. (LIXT) has a market cap of $3.2M as of April 16, 2025.
What is the P/E ratio for Lixte Biotechnology Holdings Inc. stock?
The price to earnings (P/E) ratio for Lixte Biotechnology Holdings Inc. (LIXT) stock is 0 as of April 16, 2025.
Does Lixte Biotechnology Holdings Inc. stock pay dividends?
No, Lixte Biotechnology Holdings Inc. (LIXT) stock does not pay dividends to its shareholders as of April 16, 2025.
When is the next Lixte Biotechnology Holdings Inc. dividend payment date?
Lixte Biotechnology Holdings Inc. (LIXT) stock does not pay dividends to its shareholders.
What is the beta indicator for Lixte Biotechnology Holdings Inc.?
Lixte Biotechnology Holdings Inc. (LIXT) has a beta rating of 0.19. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.